Skip to Content

Join the 'Breast Cancer - Adjuvant' group to help and get support from people like you.

Breast Cancer - Adjuvant News

Never Too Old for a Mammogram?

Posted 7 days ago by Drugs.com

MONDAY, Nov. 28, 2016 – Women who think they're too old to worry about mammograms may want to reconsider the age at which their breast cancer screening years are behind them, a new study suggests. Based on an analysis of nearly 7 million mammograms over a seven-year period, "the benefit continues with increasing age up until 90," said study author Dr. Cindy Lee. She is an assistant professor in residence at the University of California, San Francisco. The question of when to stop having mammograms has been widely debated. In 2009, the U.S. Preventive Services Task Force issued new guidelines, saying there wasn't enough evidence to assess the balance of benefits and harms of screening mammography in women aged 75 and older. Lee and her colleagues looked at patient age, mammogram results, recall rates for more testing, biopsy referrals and biopsy results. The investigators also looked at ... Read more

Related support groups: Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Body Imaging

Depressed Women Less Likely to Get Best Breast Cancer Care: Study

Posted 17 days ago by Drugs.com

FRIDAY, Nov. 18, 2016 – Breast cancer patients with a history of depression are less likely to receive recommended care for their disease, a new study finds. The study included more than 45,000 Danish women diagnosed with early stage breast cancer between 1998 and 2011. Of those, 13 percent had been treated with antidepressants and 2 percent had previously visited a hospital for depression. Compared with those who never took antidepressants, patients who used antidepressants were much less likely to receive recommended breast cancer treatments and had shorter overall survival, according to Dr. Nis Suppli, of the Danish Cancer Society Research Center in Copenhagen, Denmark, and colleagues. In addition, the researchers found that antidepressant use was tied to shorter breast cancer-specific survival: five years after cancer diagnosis, 13 percent of patients who used antidepressants had ... Read more

Related support groups: Depression, Major Depressive Disorder, Breast Cancer, Dysthymia, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

New Drug May Brighten Outlook for Advanced Breast Cancer

Posted 18 days ago by Drugs.com

WEDNESDAY, Nov. 16, 2016 – A recently approved drug can help slow the progression of advanced breast cancer, a new clinical trial confirms. The drug, called palbociclib (Ibrance), was approved in the United States last year for treating advanced cases of ER-positive breast cancer. That means the cancer uses the hormone estrogen to help fuel its growth. The approval was based on an earlier-stage study where the drug, used along with a standard drug called letrozole (Femara), helped keep women's cancer at bay. Palbociclib doubled the time patients remained progression-free compared to letrozole alone. The new findings, published in the Nov. 17 New England Journal of Medicine, confirm the earlier results in a larger group of women. "We found that the degree of clinical benefit was, again, remarkable," said lead researcher Dr. Richard Finn, an assistant professor of medicine at the ... Read more

Related support groups: Breast Cancer, Femara, Breast Cancer, Metastatic, Letrozole, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Ibrance, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Palbociclib

Exercise Good for Cancer Patients During, After Treatment

Posted 20 days ago by Drugs.com

TUESDAY, Nov. 15, 2016 – Exercising during and after cancer treatment is safe and improves quality of life, fitness and physical functioning, new research indicates. Benefits occurred with all types of exercise, said study author Brian Focht. "Overall, resistance exercise, aerobic exercise – and even a combination of aerobic and resistance – resulted in improvement in fitness and quality of life and physical function," said Focht. He directs the exercise and behavioral medicine lab at the Ohio State University Comprehensive Cancer Center in Columbus. More than 15 million people in the United States are cancer survivors. That number is expected to rise to 20 million within 10 years, according to background information with the study. But current guidelines about exercise for cancer survivors are broad, suggesting simply that patients should try to be active, Focht noted. The study ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

Self-Exam of Breast Should Be Thorough

Posted 12 Nov 2016 by Drugs.com

FRIDAY, Nov. 11, 2016 – There are five steps women should follow to ensure a monthly breast self-exam is effective, an expert says. "The most important thing about a breast self-examination is to know your breasts," said Dr. Laura Kruper, a breast cancer surgeon at City of Hope in Duarte, Calif. "Many women detect breast cancers or breast lumps themselves and that can be the beginning of an important conversation with your doctor." "Start by looking for differences between your breasts. Good breast self-exams should be concerned with both the look and feel of breasts. The look element should be performed while either standing or sitting in front of a mirror, with your clothes removed," she added in a City of Hope news release. "Examine both breasts and look for: visible lumps; any unusual differences between the two breasts; dimpling or indentations in the breast tissue; redness, ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Diagnosis and Investigation, Breast Cancer - Palliative, Fibrocystic Breast Disease

Intense Chemo Offers Little Benefit for Early Breast Cancer: Study

Posted 9 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 9, 2016 – A more intense type of chemotherapy offers little benefit over standard chemotherapy for women with high-risk early breast cancer, European researchers report. Known as tailored dose-dense chemotherapy, the treatments are given over a shorter period of time without increasing the overall dose. It has been suggested as a way to improve the effectiveness of the treatment for early breast cancer. However, the European study did not find a difference in recurrence-free survival or overall survival after five years of follow-up. The investigators did find that the dose-dense group had better event-free survival, defined as the time to any breast cancer relapse, cancer in the opposite breast, other malignant growths or death from any cause. Despite the results, a U.S. breast cancer expert said there is still a role for the approach in certain women. Researchers from ... Read more

Related support groups: Provera, Depo-Provera, Breast Cancer, Lupron, Tamoxifen, Medroxyprogesterone, Arimidex, Lupron Depot, Femara, Zoladex, Breast Cancer, Metastatic, Anastrozole, Evista, Letrozole, Megestrol, Megace, Herceptin, Aromasin, Exemestane, Breast Cancer - Adjuvant

Breast, Cervical Cancer More Deadly in Developing Nations: Report

Posted 2 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 2, 2016 – Women in developing countries are more likely to die of breast and cervical cancer than those in richer nations, researchers report. But, they added, many of the deaths in these low- and middle-income countries could be prevented with cost-effective treatment. "The global community cannot continue to ignore the problem – hundreds of thousands of women are dying unnecessarily every year, and the need for affordable access to cancer care is projected to increase in the coming decades, as many of the poorest countries face rising rates of cancers," said study co-author Richard Sullivan. Sullivan is a professor of cancer and global health at King's College London in England. The number of breast cancer cases diagnosed worldwide could almost double, from 1.7 million in 2015 to 3.2 million by 2030 if urgent action is not taken, the researchers said. Meanwhile, the ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Breast Reconstruction Worthwhile for Older Women: Study

Posted 28 Oct 2016 by Drugs.com

FRIDAY, Oct. 28, 2016 – Older women who have had a breast removed due to cancer benefit as much as younger women from breast reconstruction, a new study shows. Since the researchers also found that older women did not suffer more complications than younger women, age alone should not disqualify a woman from having the surgery, they added. Their study involved more than 1,500 women in the United States and Canada who had breast reconstruction after breast removal (mastectomy). The study authors included almost 500 women under age 45; about 800 between 45 and 60; and 234 over 60. Women in the two younger groups were just as satisfied with their new breasts as before the surgery while women 60 and older were slightly less so. Women who got breast implants had fewer complications than those whose own tissue was used for breast reconstruction. Among those who had implants, 22 percent of the ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention

High Rate of Antidepressant Use After Cancer

Posted 27 Oct 2016 by Drugs.com

WEDNESDAY, Oct. 26, 2016 – Treatment for depression and anxiety is nearly twice as common among U.S. cancer survivors as it is for those who never had the disease, a new study finds. Among more than 3,000 adult cancer survivors, 19 percent reported taking medication for anxiety, depression or both, researchers found. But when the research team looked at nearly 45,000 adults with no history of cancer, they found just one in 10 used these medications. "Overall, these findings are sobering," said lead researcher Nikki Hawkins, a behavioral scientist at the U.S. Centers for Disease Control and Prevention. "We've come a long way in treating cancer medically, but these data tell us cancer can take a serious psychological and emotional toll for many years, even after treatment is complete," she said. Hawkins said it's remarkable that nearly one in five cancer survivors is taking medications ... Read more

Related support groups: Depression, Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Cancer, Major Depressive Disorder, Social Anxiety Disorder, Breast Cancer, Prostate Cancer, Colorectal Cancer, Dysthymia, Melanoma, Breast Cancer - Adjuvant, Cervical Cancer

Rates of Preventive Mastectomy Doubled in a Decade, and Fear Is a Factor

Posted 18 Oct 2016 by Drugs.com

TUESDAY, Oct. 18, 2016 – Fear of cancer recurrence seems to be a primary reason why breast cancer patients choose to have their cancer-free breast removed at the same time as their affected breast, a new study finds. The rate of this type of surgery – called contralateral prophylactic mastectomy (CPM) – doubled in the United States in the past 10 years. Recent data suggest that up to 25 percent of newly diagnosed breast cancer patients undergo this procedure, the study authors noted. The researchers wanted to find out why so many patients decide to have the surgery. They looked at breast cancer patient postings in an online health community. Along with fear of cancer recurrence, many women believe that a double mastectomy is the best treatment for breast cancer, the investigators found. Some patients had already had a breast cancer recurrence and decided on preventive mastectomy in ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

Breast Cancer Deaths Continue to Decline in U.S.

Posted 14 Oct 2016 by Drugs.com

THURSDAY, Oct. 13, 2016 – The racial gap for breast cancer deaths is closing, particularly among younger women, U.S. health officials reported Thursday. Breast cancer death rates are down overall for both white and black women, though there's still a disparity between the races. Between 2010 and 2014, death rates dropped faster among white women than among black women, about 2 percent a year versus 1.5 percent, according to the study from the U.S. Centers for Disease Control and Prevention. However, among women under 50, the death rate was the same for both races, the researchers found. "We hope that the signal we are seeing in younger women we will see in older women as time progresses," said lead author Dr. Lisa Richardson. She's director of the division of cancer prevention and control at the CDC. "Historically, black women have had higher mortality rates and they still do overall, ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

Freeze Therapy: An Alternative to Breast Cancer Surgery?

Posted 12 Oct 2016 by Drugs.com

TUESDAY, Oct. 11, 2016 – A freezing technique known as cryoablation might be a viable alternative to lumpectomy for treating small, early stage breast cancers, researchers report. In the small study of 86 patients, "cryoablation was shown to successfully [treat] the majority of small breast cancers with few side effects or complications," said study co-author Dr. Deanna Attai. She's an assistant clinical professor of surgery at the University of California, Los Angeles David Geffen School of Medicine. Using this minimally invasive approach to destroy cancer cells, there should be little to no change in the appearance of the breast, said Attai, immediate past president of the American Society of Breast Surgeons. The major risk, Attai said, is not killing all the cancerous cells. Another surgeon noted that although further research is still needed, cryoablation appears to be "a potential ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Renal Cell Carcinoma, Breast Cancer - Adjuvant, Breast Cancer, Prevention

Cost of Breast Cancer Chemo Varies Widely in U.S.

Posted 10 Oct 2016 by Drugs.com

MONDAY, Oct. 10, 2016 – Breast cancer chemotherapy costs can vary by tens of thousands of dollars in the United States, depending on the course of treatment doctors select, a new study finds. Even across drug regimens that achieve the same effect, insurers' costs can differ by as much as $20,000, researchers found. They found a smaller variation in patients' share of the cost across different treatment regimens. "But there still was a high financial burden for patients," said Dr. Sharon Giordano, the study's lead author. That's especially true for patients in high-deductible health plans. Their median out-of-pocket cost exceeded $5,000, and 10 percent of patients shelled out $11,000 or more, the study found. Giordano is a professor in breast medical oncology and chair of health services research at the University of Texas MD Anderson Cancer Center in Houston. She and her colleagues ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Breast Cancer - Male

More Evidence Tamoxifen, Other Meds Help Limit Breast Cancer's Spread

Posted 6 Oct 2016 by Drugs.com

THURSDAY, Oct. 6, 2016 – Treatment with tamoxifen or another class of drugs called aromatase inhibitors does cut breast cancer patients' risk of developing cancer in their other breast, a new study finds. Some breast cancers rely on estrogen to help them grow, and drugs like tamoxifen or the aromatase inhibitors (which include anastrozole) have long been prescribed to certain breast cancer survivors. Tamoxifen blocks estrogen receptors in the breast cells to hamper cancer growth. Anastrozole stops estrogen production in fat tissue, which makes small amounts of the hormone. According to background information in the new study, about 5 percent of breast cancer patients develop cancer in their other breast (contralateral breast cancer) within 10 years after their initial breast cancer diagnosis. Prior clinical trials had concluded that tamoxifen and aromatase inhibitors reduce this risk, ... Read more

Related support groups: Breast Cancer, Tamoxifen, Arimidex, Femara, Breast Cancer, Metastatic, Anastrozole, Letrozole, Aromasin, Exemestane, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Tamoxifen Hexal, Nolvadex, Tamone, Emblon, Tamoxen, Genox, Teslac, Nolvadex D

Delaying Breast Reconstruction After Cancer May Raise Patients' Anxiety

Posted 4 Oct 2016 by Drugs.com

TUESDAY, Oct. 4, 2016 – Breast reconstruction immediately after breast removal surgery due to cancer may help reduce a patient's mental distress, a new study suggests. This approach isn't always an option. However, the study finding suggests that immediate breast reconstruction "may protect breast cancer patients from a period of psychosocial distress, poor body image, and diminished sexual well-being, compared to those waiting" for delayed reconstruction, said Dr. Toni Zhong and colleagues at the University of Toronto. The study included 106 breast cancer patients who underwent breast removal surgery followed by breast reconstruction. Thirty patients had reconstruction during the same surgery as breast removal, while 76 had delayed breast reconstruction, an average of three years after the mastectomy. Before mastectomy, 26 percent of study participants had increased levels of anxiety ... Read more

Related support groups: Anxiety, Surgery, Anxiety and Stress, Breast Cancer, Breast Cancer - Adjuvant

Page 1 2 3 4 5 6 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer

Related Drug Support Groups

Lupron, tamoxifen, Femara, letrozole, Herceptin, Taxol, paclitaxel, leuprolide, epirubicin, view more... trastuzumab, Tamoxifen Hexal, Nolvadex, Tamoxen, Pharmorubicin RDF, Pharmorubicin PFS, Tamosin, Genox, Tamone, Onxol, Ellence, Soltamox, Emblon, Tamofen, Nolvadex D